The nation of Zimbabwe has turned down a substantial US healthcare agreement worth $367m (£272m) over five years due to the United States' demand for sensitive information.
This rejection became public following a internal memorandum from December was leaked, indicating that President Emmerson Mnangagwa felt the arrangement was "skewed".
An official spokesperson later stated that the United States was demanding access to biological samples for research and commercial purposes while was not willing to share the resulting advantages from future treatments.
"We are forced to start the difficult and regrettable task of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had donated more than $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for continued talks to reach a deal agreeable to both sides so the nation's vital HIV treatment initiative can proceed.
Broader Implications
This development comes after a comparable situation in Kenya, where a court blocked a similar health funding agreement after concerns were filed about the safety of citizens' health data.
Since resuming office last year, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump stated its spending was "wasteful" and his government was seeking government-to-government agreements to boost openness and responsibility.
Based on reports, Sixteen African countries have to date agreed to these new agreements, representing over $18.3bn of fresh investment.
Specifics of the Rejected Deal
This assistance for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We believe this cooperation could have provided extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently on HIV treatment through US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"Our nation was requested to provide its biological resources and data over an extended period, with no corresponding assurance of access to any medical innovations – like vaccines, diagnostics, or treatments – that might result from that provided information," his statement read.
"Effectively, our nation would supply the basic resources for scientific discovery without any certainty that the resulting innovations would be accessible to our citizens should a new pandemic emerge."
Sovereignty and Global Health
He also pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining frameworks already established through the international organization.
Mangwana cited its Pandemic Benefit-Sharing framework designed to deal with potential global health emergencies.
"This system is intended to ensure that when a country provides its data, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised solely by those with the resources to develop them."
These objections regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We are open to ongoing dialogue with our US partners on how future collaboration might be designed in a manner that respects the sovereignty and dignity of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the government's concerns, but suggested that negotiations must proceed given that much of the nation's HIV programmes were funded by international support.
"If technical issues arise, including those involving data governance or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," it commented.
This impasse underscores the ongoing debate between accepting vital international aid and safeguarding a country's data in an ever more data-driven world.